a public good project by the
Synthesis
Company
of California

© 2026

Junichiro James Kazama | doi.page

0 works0 citations0 h-index

Junichiro James Kazama

Fukushima Medical University(JP)

Publications by Year

Research Areas

Parathyroid Disorders and Treatments, Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Bone health and treatments, Bone health and osteoporosis research

Most-Cited Works

→ Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder(2013)388 cited
→ Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients(2006)381 cited
→ Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency(2004)325 cited
→ Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients(2005)208 cited
→ Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011)(2013)197 cited
→ Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure(2002)167 cited

→ Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality(2020)

166 cited

→ Sevelamer Hydrochloride and Calcium Bicarbonate Reduce Serum Fibroblast Growth Factor 23 Levels in Dialysis Patients(2005)137 cited

→ Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome(2004)132 cited

→ Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients(2005)131 cited